SCM
APEN

Soleus Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Soleus Capital Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,137,105
Closed -$6.26M – 96
2022
Q3 		$6.26M Sell
1,137,105
-2,131,843
-65% -$11.8M 0.85% 37
2022
Q2 		$11.9M Buy
3,268,948
+375,848
+13% +$1.78M 1.86% 18
2022
Q1 		$17.5M Buy
2,893,100
+598,000
+26% +$3.64M 2.26% 15
2021
Q4 		$19.3M Buy
+2,295,100
New +$20M 1.94% 18

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Soleus Capital Management's APEN Position: Q4 2022 in Review

Soleus Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 1,137,105 shares — an estimated $6.26M sold.

Soleus Capital Management first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $19.3M in Q4 2021. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

  • Soleus Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
  • Soleus Capital Management sold 1,137,105 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $6.26M.
  • Soleus Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
  • Soleus Capital Management's Apollo Endosurgery, Inc. position peaked at $19.3M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Soleus Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.